Abstract 13091: Pemafibrate Reduced Hepatic Fibrosis and Cardiac Inflammation in Cholesterol-dominant, Atherogenic-Diet Induced Steatohepatitis Model in Mice

Introduction: Pemafibrate reduces serum triglycerides level and has been reported that it also decreased hepatic triglycerides. In recent decades, the number of patients with nonalcoholic fatty liv...